HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Yi-xue Xue Selected Research

member 1 small inducible cytokine subfamily E

9/2015Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
5/2015Role of cAMP-dependent protein kinase A activity in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier.
3/2014Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway.
9/2012Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
6/2012Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
1/2011Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Yi-xue Xue Research Topics

Disease

17Neoplasms (Cancer)
09/2015 - 08/2009
16Glioma (Gliomas)
09/2015 - 03/2009
4Brain Neoplasms (Brain Tumor)
12/2013 - 03/2009
2Glioblastoma (Glioblastoma Multiforme)
01/2015 - 06/2012
2Cerebral Hemorrhage
04/2009 - 02/2007
2Brain Edema (Cerebral Edema)
04/2009 - 02/2007
1Parkinson Disease (Parkinson's Disease)
05/2014
1Brain Ischemia (Cerebral Ischemia)
02/2013
1Ischemia
02/2013
1Brain Injuries (Brain Injury)
04/2009

Drug/Important Bio-Agent (IBA)

6member 1 small inducible cytokine subfamily EIBA
09/2015 - 01/2011
4Messenger RNA (mRNA)IBA
01/2015 - 01/2011
4Evans Blue (Blue, Evans)FDA Link
06/2014 - 04/2009
4occludinIBA
12/2013 - 01/2011
3BradykininIBA
08/2015 - 08/2009
3Caveolin 1IBA
09/2012 - 09/2010
3Proteins (Proteins, Gene)IBA
04/2011 - 09/2010
3Dexamethasone (Maxidex)FDA LinkGeneric
04/2009 - 02/2007
2Untranslated RNA (Noncoding RNA)IBA
09/2015 - 09/2015
2rho-Associated KinasesIBA
09/2015 - 09/2012
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
05/2015 - 01/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014 - 06/2011
2PapaverineIBA
06/2014 - 04/2011
2AdenosineFDA LinkGeneric
12/2013 - 05/2011
2Potassium Channels (Potassium Channel)IBA
12/2013 - 05/2011
2minoxidil sulfate esterIBA
12/2013 - 05/2011
2Caveolin 2IBA
09/2012 - 09/2010
2Adenosine Triphosphate (ATP)IBA
05/2011 - 01/2011
2Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
04/2011 - 03/2009
1Fibroblast Growth Factor 1 (FGF-1)IBA
09/2015
1Threonine (L-Threonine)FDA Link
09/2015
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2015
1Serine (L-Serine)FDA Link
09/2015
1Adenosine Monophosphate (AMP)IBA
05/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2014
13-aminobenzamideIBA
05/2014
1Sodium Chloride (Saline Solution)FDA LinkGeneric
02/2013
1ErythropoietinFDA Link
02/2013
1salicylhydroxamic acid (SHAM)IBA
02/2013
1Protein Kinase CIBA
09/2012
1Carbon MonoxideIBA
09/2012
1Small Interfering RNA (siRNA)IBA
06/2012
1DNA topoisomerase II alphaIBA
06/2012
1trioctyl phosphine oxide (TOPO)IBA
06/2012
1Matrix Metalloproteinase 7 (Matrilysin)IBA
12/2011
1U 0126 (UO 126)IBA
12/2011
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2011
1Malondialdehyde (Propanedial)IBA
04/2009
1Interleukin-1beta (Interleukin 1 beta)IBA
04/2009
1MelatoninIBA
04/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2009
1CytokinesIBA
04/2009
1Aquaporin 4IBA
02/2007

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2015
1Aftercare (After-Treatment)
12/2011